Senses Disorder TRIZ Cases

Replacing native signals with heterologous sequences boosts RdCVF secretion efficiency for retinal therapy.

Segmented synthesis of KX2-391 mesylate eliminates ethyl chloride contamination, ensuring pharmaceutical purity.

An implantable pump delivers artificial cerebrospinal fluid to increase intracranial pressure and enhance turnover.

A stably tethered structure uses a dimerization and docking domain homodimer to anchor distinct antibody precursors into defined binary complexes.

Porous sintered structure replaces semi-permeable membranes to prevent variable permeability and clogging while sustaining drug release.

Thio compounds modulate TNF-α activity to treat neurodegenerative disorders while reducing toxicity.

Tricyclic pyrido-carboxamide compounds inhibit Rho kinase activity to overcome medication resistance in cardiovascular diseases, reducing blood pressure.

Aucuba japonica extract increases tear secretion volume while inhibiting corneal morphology changes through solvent extraction of active plant compounds.

4-phenylbutyrate alleviates endoplasmic reticulum stress to inhibit viral protein synthesis, overcoming acyclovir resistance in herpes simplex virus infections.

Triazole-based polymer-prostaglandin conjugates provide sustained drug delivery while biodegrading to eliminate surgical removal needs.

Cholinergic and alpha-stimulant agents synergize to improve near vision while minimizing side effects from chronic use.

Segmented peptide sequences guide vinyl sulfone warheads to specific caspases, resolving the trade-off between inhibition permanence and target selectivity.

Selective deuterium substitution at bis-allylic positions stabilizes linolenic acid against reactive oxygen species without slowing metabolic processing rates.

Autoclaving non-sterile hyaluronic acid preserves cyclosporin A potency while eliminating irradiation degradation and reducing manufacturing costs.

Subantimicrobial chemically modified tetracycline derivatives inhibit retinal degeneration through zinc chelation and oxidative stress reduction.

Deina hydrocortisone derivative resolves limited treatment options for atrophic tissues by restoring physiological conditions through parameter changes.

Heat-treated clear tomato concentrate combined with carotenoids overcomes limited potency in natural products by inhibiting nitric oxide and TNF-alpha production.

Fulvene analogs target overexpressed Nox enzymes to suppress reactive oxygen species, selectively destroying cancer cells while sparing healthy tissue.

Novel 1,2-dihydroquinoline derivatives with specific 5-position substituents exhibit strong glucocorticoid receptor binding activity.

Oxazole compounds modulate NAAA activity, avoiding metabolic disruptions from traditional blockers.

Heterocyclic carboxylic acid compounds activate the ferric state of soluble guanylate cyclase under oxidative stress, restoring nitric oxide signaling.

Positive allosteric modulators enhance hemoglobin formation via PPARγ agonists, avoiding exogenous EPO immunogenicity.

Peptides under 24 amino acids reduce mucus production by extracting essential functional sequences to resolve solubility and efficacy trade-offs.

Structural modifications of fluorescein extend working lifetime in the retinal vasculature while reducing adverse reactions and vitreous leakage.

SERCA inhibitors induce unconventional secretory pathway transport of aggregated glycosylation-defective proteins from the endoplasmic reticulum.

Formula I benzoazepin compounds activate PPAR-delta receptors to increase HDL-C and lower LDL-C, addressing statin limitations.

Conditioned media from embryonic stem cell-derived mesenchymal stem cells promotes endogenous tissue repair without invasive isolation procedures.

Incubating platelet-rich plasma increases viscosity, prolonging contact with inner ear nerve cells to improve hearing thresholds.

Oxygen linked pyrimidine compounds inhibit specific kinases to reduce harm to healthy cells during cancer treatment.

Segmented antibody design blocks SCF-mediated c-Kit signaling, reducing mast cell activity and fibrosis while minimizing side effects.

Combining tertiary amine oxide with polyquaternium-1 reduces microbial populations by two log orders while minimizing eye irritation.

Novel saturated-ring-fused dihydropyrimidinone compounds antagonize RORγ, addressing limited efficacy and side effects in autoimmune disease treatments.

Upregulating carboxylesterase 1 via AAV vectors enhances cholesterol efflux to prevent drusen formation and lipid accumulation in retinal pigment epithelium.

Sorbitol interferes with galactomannan-borate cross-linking to prevent rapid viscosity changes that cause blurring while maintaining lubrication.

Indole derivatives stabilize hyperphosphorylated hUPF1 to prevent interaction with hSMG5.

Alcaftadine combines antihistamine and mast cell stabilizing properties for ocular allergy relief.

Directed differentiation of induced pluripotent stem cells into retinal ganglion cells for therapeutic transplantation.

Modified antisense oligonucleotides resolve insufficient inhibition potency by targeting specific CTGF mRNA sequences to reduce fibrotic scarring.

Site-directed mutagenesis of plasmin catalytic domains reduces autocatalytic degradation, enabling stable long-term storage for thrombolytic therapies.

Stem cell-conditioned medium from dental pulp delivers growth factors to promote tissue repair and neurological function.

Topical aldosterone antagonists resolve inadequate symptom relief from lubricants by reducing inflammation and improving meibum secretion quality.

An expandable lacrimal implant retains position via swelling while delivering sustained therapeutic agents, addressing drug loss from overflow.

Pyrrolo[2,3-b]pyrazinyl acrylamides selectively inhibit Janus kinase 3 while sparing Janus kinase 2 signaling to treat immune diseases.

EP2 agonist compounds reduce intraocular pressure while avoiding iris pigmentation and eye irritation caused by FP receptor agonists.

Compound A neutralizes reactive aldehydes like malondialdehyde, reducing accumulation and mitigating toxicity in neurodegenerative and ocular diseases.

Extracellular matrix adheres neural retina and pigment epithelial cells in sphere-like aggregates, enabling long-term engraftment.